secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0001641172-25-019652
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SRx Health closes $7.3M convertible note financing and secures $50M equity line of credit
--------------------------------------------------------------------------------

- Closed $7.3M convertible note financing led by insiders and existing investors; notes bear 8% interest, mature July 2027.
- Notes convertible at $0.6274 per share; warrants issued to purchase 21,338,062 shares at $0.6274, exercisable for 3 years.
- Secured $50M equity line of credit (ELOC) with a lead investor; $1M in commitment shares issued at a discount to market.
- Proceeds to support U.S. M&A pipeline, Canadian specialty pharma expansion, and working capital for growth initiatives.
- Company granted security interest in substantially all U.S. business assets as collateral for the note financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000164117225019652/0001641172-25-019652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000164117225019652/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-019652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer